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Background: Airway fibroblasts have become a critical addition to all facets of structural lung tissue changes such
as in human asthma and chronic obstructive pulmonary disease, but little is known about their role in the equine
recurrent airway obstruction, a disease that resembles to the human asthma. Since the equine bronchial fibroblasts
(EBF) have not been isolated and characterized yet, the use of defined medium was investigated.
Results: Primary EBF were cultured on non-collagen coated flasks without serum or in the presence of fetal bovine
serum (FBS) or horse serum (HS) or in serum depleted medium. EBF cultured in serum-free basal media and those
serum deprived were not able to proliferate and even exhibited considerable cell death. In media containing FBS or
HS, proliferation of the cells was reproducible between different primary cultures and cells demonstrated expression
of vimentin. Large variations were found in the ability of FBS and HS to support growth and differentiation of EBF
in monolayer culture. Indications of growth-promoting actions, increasing passage number as well as maintaining
fibroblast morphology were found rather in FBS than in HS. EBF culturing in HS needed longer doubling and
confluence time. The protein content of the cell pellets was higher in EBF cultured in medium containing HS than
FBS. Alpha-smooth muscle actin seemed to be less expressed in EBF cultured in medium containing FBS than those
in HS.
Conclusions: In sum, serum addition to basal EBF medium enhanced EBF differentiation into myofibroblasts, and
these findings are useful to develop in vitro fibroblast culture models that mimic in vivo physiological processes
and to study airway disease mechanisms and remodeling.
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Chronic airway diseases like human bronchial asthma and
chronic obstructive pulmonary disease (COPD) and the
equine recurrent airway obstruction (RAO) principally
characterized by bronchial hyperreactivity and airflow ob-
struction result from several factors including structural
alterations of the airway wall and cell function. Such air-
way remodelling is a common feature of abnormal depos-
ition of extracellular matrix (ECM) components in airway* Correspondence: gabraham@rz.uni-leipzig.de
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reproduction in any medium, provided the ormesenchymal layer associated with airway wall thickness
[1-3]. Airway fibroblasts and those cells differentiated into
myofibroblasts contribute to sub-epithelial fibrosis linked
to airway remodelling by producing ECM proteins such as
collagen, fibronectin and proteoglycans [4,5].
There are several well characterized human fetal lung
fibroblast cell lines that are cultured in defined media and
for use as in vitro cell model to study airway diseases and
remodeling, for example, HFL-1 [6], IMR-90 [7], HEL299,
MCR-5 [8], WI-38 [9] and GM 06114 [10]. Culture of
primary bronchial fibroblasts exists for human [11,12],
mice [13] and rats [14]. However, there is currently neitherLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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tures nor there are such cell lines for this species.
Not all cells have the same requirements for growth and
survival. With this regard, for successful growth, mainten-
ance and expression of differentiated metabolic functions
of human or animal cells in vitro, either primary cultures
or continuous cell lines, appropriate culture conditions are
required that mimic the physiological conditions in vivo
and situ. In fact, it is well known that serum represents a
fundamental source of nutrients, cytokines and adhesive
molecules necessary for in vitro cell growth, metabolism
and to stimulate proliferation [15]. In serum-free medium,
only the addition of growth factors could initiate mouse
lung fibroblast proliferation [16]. On the other hand, pro-
liferating primary cardiac and dermal fibroblasts as well as
established cell lines have been synchronized into a non-
dividing G0-phase to cell cycle by serum withdrawal [17]
which favour fibrotic processes or cause cell death [18,19].
While significant advances are made to culture conditions
of permanent cell lines, current research is lacking that
compares cultures of primary airway fibroblasts in differ-
ent serum origins added to a standard culture medium or
serum depleted medium, and how this may affect their dif-
ferentiation. The sera that most widely used are bovine
origin (adult or new born or fetal origin); as well the horse
serum has been seen as an alternative to provide growth
factors and hormones in modern cell biology. Indeed, al-
most it is not known about the responses of primary air-
way fibroblast cultures to horse serum factors.
Aim of the present study was to develop a primary bron-
chial fibroblast culture technique and investigate the influ-
ence of horse serum in comparison to FBS on cell viability,
morphology and immunocytochemical characteristics, cell
proliferation and α-smooth muscle actin expression (α-
sma) to further understand the mechanism of peribron-
chial fibrosis (airway remodelling) in the equine RAO.
Results
Effect of serum absence and serum withdrawal on
primary EBF culture
Primary EBF cultured without serum presence in basic
DMEM failed to attach and to proliferate and those at-
tached, disappeared completely from the flask surfaces
within 1-week of culture. Also, we tested whether conflu-
ent EBF cultured in DMEM can be affected by serum
withdrawal. Serum withdrawal led to modification of EBF
number in culture; they exhibited detachment within three
days of serum starvation (data not shown). Even the
addition of 10% FBS after 24 h did not significantly en-
hance EBF attachment and proliferation.
Cell viability and morphology under FBS and HS influence
Cell yield from digested bronchial tissue was consistent.
Under both culture conditions, EBF were stained withtrypan blue and the percentage of viable cells was similar,
usually > 95%. No significant evidence of cell necrosis or
cell apoptosis was observed under inverted light micro-
scopic analysis. With regard to cell morphology, EBF cul-
tured in DMEM with 10% FBS appeared to be typically
flattened and spindle-shaped (with a homogenous cyto-
plasm) over several weeks of passages compared to EBF
cultured in DMEM with 10% HS (Figure 1A). In medium
containing FBS, EBF were grown over the growth surface
with only loose cell-cell-contact until reaching confluence
and then formed tight parallel lines which remained as typ-
ical fibroblastic monolayer until passage 15. EBF between
passages 16 – 20 started to change their morphology: cells
were large, flat and more polygonal shaped, with a large,
heterogeneous nucleus. At the same time, cell growth was
rapidly reduced and cell viability was diminished. In con-
trast, EBF cultured in the presence of HS showed altered
morphological changes within 2 days of culture; cells were
small and more compact in shape combined with granula-
like dark structures in the cytoplasm (Figure 1C). More-
over, cells grew in clusters and chains and failed to reach
confluence within a week. This morphological behaviour
of EBF was seen under this culture conditions until pas-
sage 7, but thereafter, EBF failed to proliferate regularly
and decreased in their viability (passage 9). Under both
culture conditions, most EBF (>99%) were positive for
vimentin, but with more characteristic filamentous struc-
tures within the cytoplasm in medium containing FBS
(Figure 1B) than in the presence of HS (Figure 1D).
Sera effects on cell population, proliferation and total protein
Number of passages and proliferation differed significantly
between the two culture conditions. By routinely passa-
ging primary EBF (once a week), EBF maintained their
typical morphological fibroblastic properties up to passage
20 in culture medium containing fetal bovine serum,
whereas EBF in horse serum did exhibit significantly lim-
ited proliferation rate merely up to passage 9 (Figure 2A).
Under both experimental conditions, growth curves of
EBF showed similar initial 24 h lag-phase. The population
data began to exhibit significant differences between the
two conditions until day 4 of EBF culture (Figure 2B). Cell
doubling time was slow in the presence of horse serum,
and here, it took significantly longer than in culture
medium containing FBS (Figure 2C). Under culture condi-
tions in the presence of FBS, primary EBF reached conflu-
ence on day 4 but not in the presence of HS. Indeed,
significant differences between serum groups were not
found on day 6 and 8. Total protein content of the cell
monolayers did not reveal significant difference between
the two experimental conditions until day five (Figure 2D),
while after day six the amount of total protein increased
under HS condition and statistically differed from FBS
condition, though cell number was the vice versa.
Figure 1 Morphological and immunocytochemical appearance of EBF cultures in the presence of FBS or HS. Phase contrast microscopy on
day 3 of FBS culture (A) and HS culture (C) (Magnification: x40); Expression of Vimentin by EBF cultured in FBS (B) and HS (D) (Magnification: x400).
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pared on maximum passage, population doubling time
and total protein content of EBF, there was no remark-
able differences between them (Figure 3). Moreover, cell
proliferation was compared between freshly isolated and
cryopreserved EBF. We did not observe any effect of cryo-
preservation on EBF proliferation (Figure 4); so routinely,
thawed cells could be used for experimental purposes.
Furthermore, we assessed the effect of time-dependent
withdrawal of fetal bovine serum on cell proliferation in
sub-confluent primary equine bronchial fibroblasts by
[3H]-thymidine incorporation assay (Figure 5). 10% FBS
induced markedly EBF proliferation compared to EBF
cultured under serum withdrawal for 24 and 48 h. Even
if this investigation was carried out in two to four cell
isolates (n = 2) in triplicates, the results indicate that
after 48 h of FBS deprivation, cells almost stopped to
proliferate in comparison to 24 hours serum withdrawal.
α-Smooth muscle actin expression
To evaluate differentiation of fibroblasts into myofibro-
blasts, the expression of α-SMA was assessed in cells
under culture conditions in the presence of FBS and HS.Under both experimental conditions, α-SMA was detect-
able in all cell lysates. In the presence of HS, α-SMA was
significantly expressed in comparison to EBF cultured in
medium containing FBS (Figure 6A). The expression of the
control protein β-actin also differed between both culture
conditions (Figure 6A); in the presence of HS, it tended to
increase even if not statistically significant. Also, when two
different batches of FBS and HS were used, and the effect
on α-SMA and β-actin expression was compared, no sig-
nificant difference was observed (Figure 6B, C).
Discussion
The overall aim of the present investigation was to assess
viability, morphological and proliferation differences of
primary bronchial fibroblasts of the horse subjected to
basal medium without serum, or first serum containing
but later serum-depleted medium, in the presence of fetal
bovine serum or horse serum. The results highlight differ-
ences in examined parameters when primary EBF were
cultured within these differing conditions. In the absence
of serum, basal medium DMEM did not support EBF at-
tachment and proliferation; serum withdrawal in sub-
confluent EBF has also led to decreased cell proliferation
Figure 2 Effect of FBS and HS on cell growth, doubling time, protein content and passage number. EBF were passaged every week and
seeded in a density of 2 × 104 cells/cm2. EBF cultured in 10% FBS keep proliferating over a longer period than in 10% HS (A). EBF were seeded
in 6-well-plates at a density of 2 × 104 cells/cm2. Effect of HS and FBS on growth curve (B), population doubling takes longer in HS than in FBS
(calculated between day 1 and day 3) (C) and effect of HS and FBS on total protein amount over 8 days (D). Data are presented as means ± SEM.
(*p < 0.05, **p < 0.01, n = 10).
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cantly affecting cell growth and differentiation were the
sera types added to basal DMEM. EBF cultures were
established from freshly isolated EBF (P0) or from frozen
isolated EBF. Despite cryopreservation, the proliferation
data generated from frozen cells were similar to those
from freshly solated and further cultured EBF.
After short-term trypsin digestion of peeled and minced
equine bronchial mucosa and from cultures of epithelial
cell mixture in DMEM containing FBS, we could observe
a complete disappearance of epithelial cells within 1-week
and instead five days later a complete coverage of culture
flasks with viable primary equine bronchial fibroblasts.
Thus, DMEM does not support epithelial cell growth des-
pite the presence of serum. This isolation procedure is de-
scribed, to our knowledge, the first time for these cells and
resulted in reproducible large cell yields with typical mes-
enchymal cell properties. EBF cultured in serum-free
DMEM were, however, not only unable to proliferate but
also were non-adherent after seven days in culture. Fromthis result, indeed, it is difficult to point out the proteins
which are present in serum and absent in the basal
medium that are essential for primary EBF growth. The
reason why EBF disappeared seems to be, even if we did
not proof, the occurrence of apoptosis and necrosis. Thus,
it can be argued that under serum-free conditions in our
cultures EBF-specific growth factors which are usually
present in serum are missing. But in many established per-
manent cell line culture under serum-free conditions
[20,21] the serum-free environment did support growth
and differentiation with clonal growth as well as mass cul-
ture (for review see [22]).
Although recent efforts have shown that human mes-
enchymal stem cells and primary epithelial cells can be
isolated and expanded long-term in serum-free medium
[23-26], no published work had shown whether human
or animal primary airway fibroblasts are able to expand
under serum-free conditions for long-term in culture.
The selective nature of serum-free media formulations
could be used in primary cultures of tissue explants by
Figure 3 Effect of FBS and HS batches on EBF passage number, population doubling and total protein content. Under standard culture
conditions as described in material and methods, cells were subjected to obtain (A) maximum passage number (n = 2), (B) population doubling
(n = 5) and (C) total protein amount (n = 2). F1 and F2 represent FBS batches, and H1 and H2 the HS batches.
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might quantitatively influence experiments with primary
cells obtained from tumor tissues. Presumably, in our
case, the serum-free condition should be optimized for
enhanced primary fibroblast expansion by adding growth
factors which have to be further investigated. In sum,
understanding of these processes is essential in under-
standing the use of these cells as in vitro model and to
study their role in airway remodelling during respiratory
disease mechanisms.
The importance of serum supplementation for cell at-
tachment, growth and passaging of in vitro proliferating
cells [27] as well as the influence of serum deprivation
on permanent cell line proliferation and cycle [28] areFigure 4 Effect of cryopreservation on EBF passage number and pop
subjected to obtain (A) maximum passage number (n = 3) and (B) populat
treated as described under Figure 2.well known. On the other hand, no data are available on
the effect of time–dependent serum withdrawal on pri-
mary airway fibroblast proliferation and differentiation.
Since serum components might affect cell stimulation,
many studies in vitro are conducted in the absence of
serum, and cells can be deprived of serum for 1 – 8 days
[29,30], and thus, the aim of the present study was to in-
vestigate the response to serum withdrawal for 24 to
48 hours in sub-confluent primary equine bronchial fibro-
blasts which were first cultured in DMEM containing 10%
FBS. In our study, we have clearly demonstrated a marked
time-dependent decrease in [3H]-thymidine incorporation
in cells deprived of serum for 24 to 48 hours, suggesting
discontinuation of proliferation in the absence of FBS.ulation doubling. Under standard culture conditions, cells were
ion doubling (n = 2). Thawed cells were used after 2 passages and
Figure 5 Effect of serum-deprivation on [3H]-thymidine
incorporation. Sub-confluent EBF were subjected to serum
deprivation for 24 and 48 hours. Cell proliferation was determined
by [3H]-thymidine incorporation (n = 2).
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in the medium and the number of attached cells was de-
creasing, indicating altering cell viability and morphology,
in agreement with data found for cardiac fibroblasts [18].
These findings show that EBF in primary cultures are not
able to adapt to serum deprivation for a given time, pre-
sumably sufficient serum growth factors are not available.
Moreover, we have tested the effects of sera types on
proliferation, morphology, population doubling and via-
bility of primary equine bronchial fibroblasts. The resultsFigure 6 Sera effects on β-actin and α-SMA expression. Western blots
DMEM containing 10% FBS or HS. Densitometry of β-actin and α-SMA was
expression than EBF cultured in FBS (n = 5). Serum batch of (B) FBS and (C
batches, and H1 and H2 the HS batches. Data are presented as means ± SEhighlight striking differences in cell proliferation, morph-
ology, passaging time and number as well as total protein
amount and α-SMA expression when EBF were cultured
within these differing conditions. Both FBS and HS are
natural products, presumably, with varying concentrations
of growth factors within different batches; however, the ef-
fects measured in our study were not dependent on batch/
lot number. EBF grown in DMEM containing 10% FBS
continue to proliferate even after reaching confluence,
whereas these same cells, when cultured in DMEM con-
taining 10% HS, had relatively limited proliferation rate,
longer population doubling time and somehow quite dif-
ferent morphological features. Cells in HS were smaller,
chain-forming and more compact in shape with dark cyto-
plasmic granules which can be related to the occurrence
of abnormal protein accumulation than those in FBS, and
they failed to reach confluence. In concordance, sera types
affect other various cell types in a similar way: bovine adi-
pocytes and sheep skeletal muscle satellite cells proli-
ferated rapidly, when FBS was supplemented to growth
medium instead of HS; thus, FBS-containing medium is
often used as growth medium in these cultures [31,32].
On the contrary, equine chondrocytes could equally pro-
liferate under both conditions [33]. Even if they are equine
cells, it is noteworthy to find that EBF exhibit a preference
for fetal bovine serum factors over the horse serum fac-
tors, whereas the vice versa has been seen for neural cellswere performed on whole cell lysate from EBF cultured for 4 days in
calculated by SynGene. (A) EBF cultured in HS show a higher α-SMA
) HS (n = 2) did not affect α-SMA expression. F1 and F2 represent FBS
M. (*p < 0.01).
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is appropriate for neuronal cell cultures [34,35].
Moreover, despite the short passaging time and limited
proliferation and population doubling rate, increased α-
SMA expression was accompanied by higher protein
amount in the presence of horse serum than in bovine
serum, suggesting that HS might stimulate fibroblast dif-
ferentiation into myofibroblasts. It is well known that
myofibroblasts are able to produce large amount of extra-
cellular matrix (ECM) proteins, as well as growth factors
and cytokines and express cytoplasmic contractile struc-
tures including α-SMA. Thus, it seems that the horse
serum increases the protein content in EBF by increasing
synthesis of structural proteins, ECM and cytokines. In-
deed, it is not yet known if differential expression of α-
SMA and protein is functionally relevant.
Conclusions
Fetal bovine serum favors fibroblastic morphology with
enhanced proliferation rate, population doubling, passage
number and triggers cell differentiation (as vimentin stain-
ing showed), suggesting serum factors essential for the
equine airway fibroblasts are available in the fetal bovine
serum, whereas in the horse serum cells there were signs
of degeneration or cell granularity. Moreover, we can con-
clude that serum withdrawal for 48 hours rather decrease
EBF adaptation and enhance cell detachment than the
24 hour FBS depletion and in the latter case cell viability
was though not altered, thus, EBF cultured in 10% FBS
represent a good model allowing studying the response to
drugs that influence cell proliferation and pathways of air-
way remodeling in airway diseases.
Study limitation: Animal serum is a complex mixture of
a large number and variety of components; therefore, it is
difficult to assess, at this stage, the significance of the obser-
vation that horse serum inhibits the programmed progress
of equine airway cells through the lineage of differentiation
in cultures.
Methods
Isolation and culture of equine bronchial fibroblasts
Primary equine bronchial fibroblasts were cultured in
Dulbecco’s Modified Eagle Medium (DMEM) supple-
mented with 200 Units/ml Penicillin, 0.2 mg/ml Strepto-
mycin, 5 mg/ml Amphotericin B (PAA Laboratories
GmbH, Pasching, Austria). Surfaces of culture flask were
not pretreated with adhesion supporting matrix like collagen.
Bronchial segment tissue samples were obtained from
adult non-diseased slaughter horses of different breed,
age and sex and slaughtered at local abattoirs (Freiberg,
Germany). Primary equine bronchial fibroblasts (EBF) were
isolated from these tissues. Briefly, the bronchial mucosa
was removed from the bronchi, washed, minced to about
1-3 mm pieces, and 500 mg tissue were digested with0.25% trypsin/EDTA (Sigma Aldrich, Deisehnhofen,
Germany) in Hanks’ balanced salt solution (HBSS)
(PAA Laboratories GmbH, Pasching, Austria) in 50-ml
Erlenmeyer glass flasks and incubated at 37°C for
2 hours in humidified atmosphere of 5% CO2. Trypsi-
nized samples were then filtered through sterile double-
layered gauze and rinsed twice with ice-cold HBSS. Cell
suspension was then further sieved through sterile
nylon cell strainers (mesh size: 40 μm) (BD Biosciences,
Franklin Lakes, NJ) and centrifuged two times to re-
move tissue debris.
To evaluate the effect of sera on proliferation and differ-
entiation of primary equine bronchial fibroblasts, we used
at least two to three different lots of cell culture appropriate
not inactivated fetal bovine serum (FBS) (Gibco, Carlsbad,
CA, USA) and horse serum (HS) (Sigma Aldrich,
Deisehnhofen, Germany). Since it was not the objective of
the study, we did not compare different serum products of
several companies. FBS is routinely used to culture other
cell lines in our laboratory, and should be tested before
use; thus, after cell isolation, final cell pellets were first re-
suspended and cultured in DMEM containing 10% fetal
bovine serum (FBS) for at least up to two passages. There-
after, EBF were trypsinized and sub-cultured under differ-
ent conditions: a) in DMEM without serum, or b) first in
DMEM containing FBS and then serum deprived, or c) in
DMEM in the presence of 10% FBS or d) in DMEM in the
presence of 10% horse serum (HS). Cells were routinely
passaged every 7 days with replacement of medium every
2 to 3 days. Unless and otherwise specified; cells were
routinely cultured in 75 cm2 flasks (Greiner Bio-One,
Frickenhausen, Germany).Cryopreservation and thawing of EBF
Certain density of isolated primary EBF were either pro-
vided for direct culturing or frozen in 1 ml DMEM con-
taining 20% FBS, 10% DMSO (Sigma Aldrich, Deisenhofen,
Germany), penicillin, streptomycin and amphotericin B in
liquid nitrogen until use. Also, some passages of EBF cul-
tures were frozen. Cells were quickly thawed at 37°C in
water bath and subsequently transferred into culture flasks
with tempered culture medium (see above). Thawed cells
were used for our study after 2 passages.Cell viability, morphology and immunostaining
For cell counting and viability testing, cells were trypsi-
nized and washed with PBS and stained with trypan blue
dye (Sigma-Aldrich, Deisenhofen, Germany). Cells exclud-
ing the dye were counted using Neubauer cell chamber.
Also, after 1-week of EBF culture in two conditions, i.e.,
DMEM+ FBS or DMEM+HS, fibroblasts were trypsi-
nized, centrifuged and an aliquot was re-suspended in PBS
with trypan blue.
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104 cells/cm2 and grown in 10 ml defined DMEM in the
presence of 10% FBS or HS. Cell morphology was evalu-
ated under inverted light microscope (Olympus CKX41).
Digital images were taken from cells at different days
and at possible confluence.
Expression of intermediate filaments in primary cultured
EBF was evaluated using immunofluorescence staining
against vimentin using a primary mouse monoclonal anti-
body and a secondary anti-mouse FITC-antibody (Dako
Deutschland GmbH, Hamburg, Germany). EBF were cul-
tured under the indicated culture conditions on glass cover
slips (Carl Roth GmbH, Karlsruhe, Germany), washed
twice with PBS after medium removal, and fixed in ice-
cold acetone for 5 min at -20°C and immunostained as
previously described [36].
Cell proliferation assay and population doubling time
To further assess the effects of sera types on cell prolifera-
tion and population doubling, EBF between passage 3 and
6 were transferred into 6-well plates (2 × 106 cells/cm2)
and cell numbers were determined manually after day 1, 2,
3, 4, 6 and 8. Each time, the average from 2 wells was
taken. The mean cell number was logarithmically trans-
formed and the linear regression slope was calculated to
derive the doubling time (DT). Proliferation rate was also
determined in cryopreserved, thawed and cultured cells.
[3H]-thymidine assay
Furthermore, cell proliferation was measured by [3H]-
thymidine incorporation assay [11]. EBF (40 000 – 60 000
cells/well) were seeded into 12-well plates, in DMEM in
the presence of 10% FBS, grown until 60% confluence, and
further cultured in the presence of 10% FBS or serum-
withdrawn for 24 or 48 hours. In all three settings, [3H]-
thymidine (37 kBq/well) (Perkin Elmer, Waltham, MA)
was added to the culture medium. 24 hours after incuba-
tion of cells with [3H]-thymidine, cells were washed in ice-
cold PBS and incorporated radioactivity was determined
by liquid scintillation counting (Beckman LS 6500 Scintil-
lation Counter). Also, in thawed and cultured EBF, prolif-
eration experiments were performed about 1-week after
thawing, to avoid a major increase in the number of cu-
mulative population doublings compared to experiments
done with fresh cells.
Cell growth determination
To measure the effect of sera on cellular growth, total
protein was measured at defined time points during cul-
ture in 6-well plates by the colorimetric method [37]. In
brief, EBF were rinsed twice in PBS and then trypsinized,
centrifuged at 500 × g for 10 min. After removal of the
supernatant, cell pellets were resuspended in PBS and
sonicated 4 rounds for 30 second. Crude cell lysateswere then diluted in 0.1 M potassium phosphate buffer
(pH 7.4), incubated with copper in alkaline solution for
10 minutes at room temperature. After addition of Folin
(Merck, Darmstadt, Germany), reduction of copper was
completed within 45 minutes and quantitative analysis
could be carried out by spectrophotometry at 660 nm
(Beckman DU640 spectrophotometer, Beckman Coulter,
Krefeld, Germany).
Western blot
Primary EBF grown in 6-well plates under different culture
conditions were harvested and suspended in sample buffer
(containing 2% SDS, 25% [v/v] glycerol, 60 mM Tris–HCl
and 0.1% bromphenol blue, 14.4 mM β-mercaptoethanol,
pH 6.8) and boiled for 5 min. Equal amounts of whole cell
lysate (2,5 × 105 cells/ml) were subjected to SDS-PAGE;
samples were separated on 12% acrylamide gel under
reducing conditions and transferred to a nitrocellulose
membrane (Whatman GmbH, Dassel, Germany). The
membrane was then blocked in 3% BSA (PAA Laborator-
ies) with TBST (20 mM Tris–HCl, pH 7.5, 150 mM NaCl
and 0.05% [v/v] Tween-20) for 1 h at room temperature.
α-SMA was detected following an overnight incubation of
samples with mouse monoclonal antibody against human
anti-α-SMA (1:1000; Sigma-Aldrich) and β-actin was de-
tected using mouse monoclonal antibody against human
anti-β-actin (1:10,000; Sigma-Aldrich) in 3% BSA-TBST at
4°C. Band visualisation was performed using alkaline phos-
phatase conjugated secondary anti-mouse igG antibody
(1:5000; Promega GmbH, Mannheim, Germany) over 1 h
at room temperature. Enzyme activity was detected using
Western Blue stabilised substrate for alkaline phosphate
(Promega). The membranes were digitalized and quanti-
tated by densitometry analysis (SynGene, Cambridge, UK).
Data and statistical analysis
All data are expressed as means ± SEM. Statistical signifi-
cance of differences was evaluated by paired two-tailed stu-
dent’s t-test using GraphPad Prism version 5.1 (GraphPad
Software, San Diego, CA, USA). P < 0.05 was considered
significant.
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